BCG-MEDAC

This brand name is authorized in United States. It is also authorized in Austria, Croatia, Estonia, Finland, France, Ireland, Lithuania, Malta, Netherlands, Poland, Romania.

Active ingredients

The drug BCG-MEDAC contains one active pharmaceutical ingredient (API):

1
UNII 2XQ558L16Z - BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN
 

BCG vaccine is an immunostimulating agent. It has anti-tumor activity, but the exact mechanism of action is not known.

 
Read more about BCG vaccine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
L03AX03 BCG vaccine L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AX Other immunostimulants
Discover more medicines within L03AX03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1127900, 1129946, 1129957, 1140725, 1140736, 1603707, 1848045, 1852893
FI Lääkealan turvallisuus- ja kehittämiskeskus 018718
FR Base de données publique des médicaments 60973899
HR Agencija za lijekove i medicinske proizvode HR-H-941213905
LT Valstybinė vaistų kontrolės tarnyba 1011850, 1018905, 1065180, 1065181
MT Medicines Authority AA565/20602
PL Rejestru Produktów Leczniczych 100119519
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W13958001, W13958002, W13958003, W13958004, W13958005, W13958006, W13958007, W13958008
US FDA, National Drug Code 0052-0603

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.